AR9: (2R,4S)-N-butyl-4-[(2S,5S,7R)-2,7-dimethyl-3,15-dioxo-1,4-diazacyclopentadecan-5-yl]-4-hydroxy-2-methylbutanamide
AR9 is a Ligand Of Interest in 3DV1 designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
| 3DV1_AR9_B_501 | 89% | 43% | 0.078 | 0.965 | 0.75 | 1.34 | - | 4 | 2 | 0 | 100% | 1 |
| 3DV1_AR9_C_501 | 88% | 41% | 0.079 | 0.961 | 0.8 | 1.37 | 1 | 5 | 1 | 0 | 100% | 1 |
| 3DV1_AR9_A_501 | 82% | 40% | 0.091 | 0.95 | 0.81 | 1.38 | 1 | 6 | 4 | 0 | 100% | 1 |
| 5QCW_AR9_B_401 | 94% | 70% | 0.068 | 0.975 | 0.42 | 0.58 | - | 1 | 2 | 0 | 100% | 1 |